Long-term therapy with bevacizumab in hereditary hemorrhagic telangiectasia. N Engl J Med 2011 Feb 17;364(7):688-9
Date
02/18/2011Pubmed ID
21323562DOI
10.1056/NEJMc1012774Scopus ID
2-s2.0-79951847934 (requires institutional sign-in at Scopus site) 33 CitationsAuthor List
Brinkerhoff BT, Poetker DM, Choong NWAuthor
David M. Poetker MD Chief, Professor in the Otolaryngology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Angiogenesis InhibitorsAntibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Bevacizumab
Epistaxis
Hemoglobins
Humans
Infusions, Intravenous
Male
Middle Aged
Telangiectasia, Hereditary Hemorrhagic